Brisbane Times
·general
·2 hours ago
Perth biotech at cutting edge of the future of medicine
Perth's Syngenis Laboratories is set to establish Australia's first commercial Good Manufacturing Practice-certified oligonucleotide facility, transforming local biotechnology. This initiative aims to keep an estimated $160 million in annual research spending within Australia, enhancing turnaround times and intellectual property control for local researchers. The facility will be a significant advancement in precision medicine manufacturing.
Summary by Glance · Brisbane Times
Newer
Next
Loving doing this? 🎉
Take it further — get the full app and never miss a moment of what's happening in Australia.
Breaking news alerts
Instant lock-screen notifications the moment big stories break across Australia.
Australian news & events
Politics, sport, weather, local events — all in one swipeable feed, updated around the clock.
Stay ahead of the news cycle
30-second summaries so you're always informed, even on your busiest days.
Loading article…
This publisher's site can't be shown here due to their security settings.
Open full article →No source link available for this article.
✨
Ask AI